Back to Sectors

LGN

Legence Corp.
3 filings tracked
industrialsconstruction engineeringMID ($2B-10B)

Signal Magnitude Chart

BEARISH | 70% | 3/30/2026 | margin compressionBULLISH | 60% | 3/30/2026 | debt restructureBEARISH | 50% | 3/30/2026 | regulatory actionBULLISH | 90% | 5/14/2026 | earnings beatBEARISH | 60% | 5/14/2026 | margin compressionBULLISH | 70% | 5/14/2026 | acquisitionBEARISH | 80% | 5/14/2026 | regulatory actionBULLISH | 90% | 5/14/2026 | earnings beatBEARISH | 60% | 5/14/2026 | margin compressionBULLISH | 70% | 5/14/2026 | acquisitionBEARISH | 80% | 5/14/2026 | regulatory actionMar 26May 26HIGHLOW
bullish
bearish
neutral

Signal Timeline

bullishMay 14

Revenue grew 105% YoY to $1.04B, driven by AI data center demand.

earnings beat
90%
bearishMay 14

Gross margins declined to 17.9% due to shift in project mix and rising costs.

margin compression
60%
bullishMay 14

Acquired The Bowers Group and Metrix Engineers to expand MEP capabilities.

acquisition
70%
bearishMay 14

Disclosure of material weaknesses in internal control over financial reporting.

regulatory action
80%
bullishMay 14

Revenue grew 105% YoY to $1.04B, driven by AI data center demand.

earnings beat
90%
bearishMay 14

Gross margins declined to 17.9% due to shift in project mix and rising costs.

margin compression
60%
bullishMay 14

Acquired The Bowers Group and Metrix Engineers to expand MEP capabilities.

acquisition
70%
bearishMay 14

Disclosure of material weaknesses in internal control over financial reporting.

regulatory action
80%
bearishMar 30

SG&A expenses grew 41.1% YoY, outpacing revenue growth and leading to a net loss.

margin compression
70%
bullishMar 30

Prepaid $780.3M of term loan debt using IPO proceeds and extended maturity to 2031.

debt restructure
60%
bearishMar 30

Material weaknesses disclosed in internal controls over financial reporting.

regulatory action
50%

Filing History

10-QMay 14, 2026

The Q1 2026 filing reveals a company in the midst of a high-stakes transformation. Legence is successfully capturing the immense demand for AI-ready facilities, but this growth is coming at a significant cost in terms of leverage and operational risk. The massive increase in backlog provides a strong cushion for future revenue, yet the compression in gross margins and the presence of material weaknesses in financial controls introduce an element of unpredictability for investors. Ultimately, the investment thesis hinges on whether Legence can successfully integrate its recent acquisitions and remediate its internal control failures before the costs of its debt load become prohibitive. While the top-line momentum is undeniable, the transition from a rapid-growth phase to a sustainable, cash-generative compounder will require a shift in focus from acquisition-led scaling to operational excellence and margin recovery.

10-KMar 30, 2026

The 10-K reveals a company at a crossroads: Legence possesses an enviable market position and a massive pipeline of mission-critical work, yet it is struggling to translate that scale into GAAP profitability. The tension between the booming demand for AI infrastructure and the company's internal operational inefficiencies is the central theme of the filing. While the balance sheet was significantly improved by the IPO, the persistent net losses and control weaknesses suggest that the transition to a public company has not yet solved the underlying cost structure issues. Investors are essentially betting on whether Legence's scale and market dominance can eventually overwhelm its high cost base and debt service requirements. The successful execution of its 'seller-doer' model and the ability to maintain a 1.6x book-to-bill ratio are positive signals, but the material weaknesses in financial reporting cast a shadow over the reliability of these metrics. The overall impact of the filing is a high-risk, high-reward profile where the operational upside is clear, but the financial execution remains unproven.